Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
La defectuosite de la carte est telle que le programme ne pourrait pas fonctionner. l'appareil ne pourrait pas analyser des hemoglobines a2 avec un programme destine a l'hemoglobine glyquee a1c.